Hypertension Drugs Market Report

Global and Region Hypertension Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：227
  • REPORT CODE：GMM957940
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Hypertension is a condition in which blood pressure rises to unhealthy levels. High blood pressure is very harmful and may lead to stroke, heart failure, heart attack and kidney disease.

    The report presented by Global Market Monitor provides a detailed analysis of the various factors driving the growth of the global Hypertension Drugs market. The report provides a comprehensive assessment of the various factors affecting the Hypertension Drugs market and provides space for strategic planning. This report describes the range of different sectors and applications that could potentially impact the future market and provides a yield analysis of the global Hypertension Drugs market over the forecast period. Lifestyle changes and elevated stress levels are increasing the prevalence of hypertension globally, thereby increasing the need for hypertension medications. The global Hypertension Drug market size is projected to reach USD 22390 million by 2026 at a CAGR of 0.7% during 2020-2026.

    The report details the trend, potential and market size of Hypertension Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Hypertension Drugsmarket, defines the market attractiveness level of Hypertension Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Hypertension Drugs industry, describes the types of Hypertension Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hypertension Drugs market and the development prospects and opportunities of Hypertension Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hypertension Drugs market in Chapter 13.

    By Player:

    • Actelion Pharmaceuticals

    • Daiichi Sankyo

    • Bayer

    • Pfizer

    • Sanofi

    • Johnson & Johnson

    • Bayer

    • Actelion Pharmaceuticals

    • Merck

    • Novartis

    By Type:

    • Systemic hypertension drugs

    • Pulmonary hypertension drugs

    By End-User:

    • Drugstore

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Hypertension Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Hypertension Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Hypertension Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Hypertension Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Hypertension Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Hypertension Drugs Consumption (2017-2022)

    • 7.2 United States Hypertension Drugs Consumption (2017-2022)

    • 7.3 Europe Hypertension Drugs Consumption (2017-2022)

    • 7.4 China Hypertension Drugs Consumption (2017-2022)

    • 7.5 Japan Hypertension Drugs Consumption (2017-2022)

    • 7.6 India Hypertension Drugs Consumption (2017-2022)

    • 7.7 South Korea Hypertension Drugs Consumption (2017-2022)

    8 Region and Country-wise Hypertension Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Hypertension Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Hypertension Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Hypertension Drugs Consumption Forecast (2022-2028)

    • 8.4 China Hypertension Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Hypertension Drugs Consumption Forecast (2022-2028)

    • 8.6 India Hypertension Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Hypertension Drugs Consumption Forecast (2022-2028)

    9 Global Hypertension Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Hypertension Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Systemic hypertension drugs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Pulmonary hypertension drugs Consumption and Growth Rate (2017-2022)

    • 9.2 Global Hypertension Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Drugstore Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Hypertension Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Hypertension Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Systemic hypertension drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Pulmonary hypertension drugs Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Hypertension Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Drugstore Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Hypertension Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Hypertension Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Hypertension Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Hypertension Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Hypertension Drugs Market Competitive Analysis

    • 14.1 Actelion Pharmaceuticals

      • 14.1.1 Actelion Pharmaceuticals Company Details

      • 14.1.2 Actelion Pharmaceuticals Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Actelion Pharmaceuticals Hypertension Drugs Product and Service

    • 14.2 Daiichi Sankyo

      • 14.2.1 Daiichi Sankyo Company Details

      • 14.2.2 Daiichi Sankyo Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Daiichi Sankyo Hypertension Drugs Product and Service

    • 14.3 Bayer

      • 14.3.1 Bayer Company Details

      • 14.3.2 Bayer Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bayer Hypertension Drugs Product and Service

    • 14.4 Pfizer

      • 14.4.1 Pfizer Company Details

      • 14.4.2 Pfizer Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pfizer Hypertension Drugs Product and Service

    • 14.5 Sanofi

      • 14.5.1 Sanofi Company Details

      • 14.5.2 Sanofi Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanofi Hypertension Drugs Product and Service

    • 14.6 Johnson & Johnson

      • 14.6.1 Johnson & Johnson Company Details

      • 14.6.2 Johnson & Johnson Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Johnson & Johnson Hypertension Drugs Product and Service

    • 14.7 Bayer

      • 14.7.1 Bayer Company Details

      • 14.7.2 Bayer Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bayer Hypertension Drugs Product and Service

    • 14.8 Actelion Pharmaceuticals

      • 14.8.1 Actelion Pharmaceuticals Company Details

      • 14.8.2 Actelion Pharmaceuticals Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Actelion Pharmaceuticals Hypertension Drugs Product and Service

    • 14.9 Merck

      • 14.9.1 Merck Company Details

      • 14.9.2 Merck Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Merck Hypertension Drugs Product and Service

    • 14.10 Novartis

      • 14.10.1 Novartis Company Details

      • 14.10.2 Novartis Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novartis Hypertension Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Hypertension Drugs

    • Figure Hypertension Drugs Picture

    • Table Global Hypertension Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hypertension Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hypertension Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Hypertension Drugs Consumption by Country (2017-2022)

    • Figure United States Hypertension Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Hypertension Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Hypertension Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Hypertension Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Hypertension Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Hypertension Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Hypertension Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Hypertension Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Hypertension Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Hypertension Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Hypertension Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Hypertension Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Hypertension Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Systemic hypertension drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Pulmonary hypertension drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Drugstore Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Systemic hypertension drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pulmonary hypertension drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drugstore Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Hypertension Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Hypertension Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Actelion Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Actelion Pharmaceuticals Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actelion Pharmaceuticals Hypertension Drugs Product and Service

    • Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Hypertension Drugs Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Hypertension Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Hypertension Drugs Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Hypertension Drugs Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Hypertension Drugs Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Hypertension Drugs Product and Service

    • Table Actelion Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Actelion Pharmaceuticals Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actelion Pharmaceuticals Hypertension Drugs Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Hypertension Drugs Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Hypertension Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Hypertension Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US